Retatrutide is hailed as a triple agonist acting on GLP-1, GIP, and GCG receptors, enhancing weight loss efforts even further
Therefore, for the insulin regimen subgroup analysis, the treatment policy estimand was used to reflect the effect of initiating treatment with oral semaglutide compared with initiating treatment with placebo, both potentially followed by either discontinuation of the trial product and/or initiation of rescue medication
Figure 5 GSTM3 Reduced the Activity of ROS To investigate the biological effects of GSTM3 on ROS, we measured the activity of ROS in PC cells by the loss- or gain-of-function strategies to knockdown or overexpress GSTM3 in PC cells
Wegovy cash list price (~$1,349/mo) and Zepbound prefilled pens (~$1,086/mo) manufacturer cash list pricing as of April 2026
The Safe Alternative to Risky Weight-Loss Drugs
In addition, the study was not randomized and cannot establish causality